Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland

BACKGROUND: An infection with high-risk human papillomavirus (HPV) is the obligatory aetiological factor for the development of cervical cancer. In Switzerland, the prevention strategy for cervical cancer is based on primary prevention via HPV vaccination and secondary prevention with an opportunist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Public Health
Main Authors: Kind, André B., Pavelyev, Andrew, Kothari, Smita, El Mouaddin, Nadia, Schmidt, Aurélie, Morais, Edith, Guggisberg, Patrik, Lienert, Florian
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216682/
https://ncbi.nlm.nih.gov/pubmed/32398057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-020-08840-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados